Customers
Trusted by the teams making the world's medicine.
5of the pharma top 20 run Katalyze
Katalyze has shortened the time required to provide insights that would have taken very long to arrive at or even conceptualize altogether.
Customer results
Progress in batch release and investigation.
Explore customer results in batch release and investigations, then see the solutions supporting that work.
Explore all solutions- Doses delivered with Katalyze
- 10M
- Deviation investigations, in half
- 50%
- Faster batch release
- 40%
- Higher yield
- Up to 8%
- Plant throughput
- Up 25%
- An analysis that took a year and $1.5-3M
- 2 days
- Live on your existing stack, not months
- 2 weeks
- Increased productivity
- 30%
- Reduced root cause analysis for deviation caused by raw material
- 25%
Find your team
Find the work that matters to your team.
Explore how scientists, quality reviewers, manufacturing teams, and technology leaders can put Katalyze to work.
- 01
MSAT
Understand why process performance changed.
Katalyze for MSAT Teams - 02
Quality
Give reviewers a clear path from finding to evidence.
Katalyze for Quality Teams - 03
Manufacturing Sciences and Engineering
Connect the process you planned to the batch you made.
Katalyze for Manufacturing Sciences and Engineering Teams - 04
CMC
Keep the reasoning behind your process decisions.
Katalyze for CMC Teams - 05
CDMO
Give your experts the evidence to answer client questions.
Katalyze for CDMO Teams - 06
Digital and IT
Put pharmaceutical AI to work with your existing systems.
Katalyze for Digital and IT Teams - 07
Enterprise AI leaders
Make the next AI use case build on the first.
Katalyze for Enterprise AI Leaders - 08
Companies preparing for commercial manufacturing
Carry your process knowledge into commercial manufacturing.
Katalyze for Companies Preparing for Commercial Manufacturing - 09
503B outsourcing facilities
Keep the evidence behind each compounded batch in reach.
Katalyze for 503B Outsourcing Facilities
Book a demo
More medicine to more patients.
Our goal is to cut the time and cost of bringing a new lifesaving drug to market in half by 2030. Explore where your team could begin.
